 | |  | |  | |  | |  | |  | |  | |  |
| IJCEM Copyright © 2008-All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711 |
Int J Clin Exp Med 2012;5(4):342-345
Case Report
Successful use of topical “Ankaferd Blood Stopper” for repetitive bleedings in an
infant with infantile hemangioma
Ali Annagür, Hüseyin Altunhan, Murat Konak, Rahmi Örs
Department of Pediatri, İzzet Baysal University, Medical Faculty, Bolu, Turkey; Department of Pediatri, Selcuk University, Selçuklu Medical
Faculty, Konya, Turkey; Department of Pediatri, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey; Professor,
Department of Pediatri, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey
Received April 27, 2012; accepted July 23, 2012; Epub August 22, 2012; Published September 15, 2012
Abstract: Infantile hemangioma (IH) is the most common vascular tumor of childhood. A major feature of this tumor is rapid growth
during a proliferation phase in the first year of life, followed by contraction through a slow involution phase. Several complications may
emerge during this course. Bleeding at the site of the lesion and infection are the most common complications. ‘Ankaferd Blood
Stopper’ (ABS) is a hemostatic agent produced as a mixture of five separate plant extracts. Provision of hemostasis by ABS is
independent from coagulation factors and the standard coagulation cascade. Furthermore, ABS has an antimicrobial effect. In this
article, we have presented a seven-year-old infant with IH on the lower lip who had been admitted with the symptoms of frequent
bleedings and infection, and who was successfully treated with topical ABS in terms of control of bleeding and infection. To the best of
our knowledge, this is the first reported case of IH that has been treated with ABS for bleeding. (IJCEM1204007).
Keywords: Ankaferd Blood Stoper, infantile hemangioma, bleeding, infection
Address all correspondence to:
Dr. Ali Annagür
Selçuk Üniversitesi, Selçuklu Tip Fakültesi
Yenidoğan Servisi, 42075 Selçuklu
Konya, Turkey.
Tel: + 90 5057906554
E-mail: aliannagur@yahoo.com
Case Report
Successful use of topical “Ankaferd Blood Stopper” for repetitive bleedings in an
infant with infantile hemangioma
Ali Annagür, Hüseyin Altunhan, Murat Konak, Rahmi Örs
Department of Pediatri, İzzet Baysal University, Medical Faculty, Bolu, Turkey; Department of Pediatri, Selcuk University, Selçuklu Medical
Faculty, Konya, Turkey; Department of Pediatri, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey; Professor,
Department of Pediatri, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey
Received April 27, 2012; accepted July 23, 2012; Epub August 22, 2012; Published September 15, 2012
Abstract: Infantile hemangioma (IH) is the most common vascular tumor of childhood. A major feature of this tumor is rapid growth
during a proliferation phase in the first year of life, followed by contraction through a slow involution phase. Several complications may
emerge during this course. Bleeding at the site of the lesion and infection are the most common complications. ‘Ankaferd Blood
Stopper’ (ABS) is a hemostatic agent produced as a mixture of five separate plant extracts. Provision of hemostasis by ABS is
independent from coagulation factors and the standard coagulation cascade. Furthermore, ABS has an antimicrobial effect. In this
article, we have presented a seven-year-old infant with IH on the lower lip who had been admitted with the symptoms of frequent
bleedings and infection, and who was successfully treated with topical ABS in terms of control of bleeding and infection. To the best of
our knowledge, this is the first reported case of IH that has been treated with ABS for bleeding. (IJCEM1204007).
Keywords: Ankaferd Blood Stoper, infantile hemangioma, bleeding, infection
Address all correspondence to:
Dr. Ali Annagür
Selçuk Üniversitesi, Selçuklu Tip Fakültesi
Yenidoğan Servisi, 42075 Selçuklu
Konya, Turkey.
Tel: + 90 5057906554
E-mail: aliannagur@yahoo.com
